Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Community series in new insights into innate immune cell-based immunotherapies in cancer, volume II.

Frontiers in immunology·2026
Same author

A DPP inhibitor suppresses periodontitis via antibacterial effect targeting Porphyromonas gingivalis.

Scientific reports·2026
Same author

FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer.

Journal of experimental & clinical cancer research : CR·2025
Same author

Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers.

Cancer medicine·2025
Same author

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.

Frontiers in immunology·2024
Same author

Editorial: New insights into innate immune cell-based immunotherapies in cancer.

Frontiers in immunology·2024

Related Experiment Video

Updated: Jun 17, 2026

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
10:44

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Published on: October 21, 2016

How much binding affinity can be gained by filling a cavity?

Yuko Kawasaki1, Eduardo E Chufan, Virginie Lafont

  • 1Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.

Chemical Biology & Drug Design
|December 24, 2009
PubMed
Summary

Optimizing drug binding affinity involves filling cavities with functionalities that enhance geometric fit. This study reveals three thermodynamic phases, leading to significant binding affinity increases and providing lead optimization guidelines.

More Related Videos

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
10:44

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Published on: October 21, 2016

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens
07:39

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Area of Science:

  • Medicinal Chemistry
  • Biophysics
  • Computational Chemistry

Background:

  • Drug development relies heavily on optimizing binding affinity.
  • Geometric fit and specific interactions are key to drug efficacy.
  • Understanding thermodynamic contributions is crucial for rational drug design.

Purpose of the Study:

  • To evaluate the thermodynamic consequences of van der Waals interactions in drug binding.
  • To investigate the impact of increasing van der Waals radii on binding affinity.
  • To identify thermodynamic signatures guiding lead optimization.

Main Methods:

  • Systematic evaluation of functionalities with increasing van der Waals radii (-H, -F, -Cl, CH(3)).
  • Analysis of thermodynamic parameters: enthalpy and entropy changes.
  • Correlation of thermodynamic signatures with binding affinity changes.

Main Results:

  • A two-orders-of-magnitude increase in binding affinity was observed.
  • Three distinct thermodynamic phases were identified.
  • Phase 1: Enthalpy gain (-1.5 kcal/mol) and entropy loss (+0.9 kcal/mol) yielding a 3.5-fold affinity increase.
  • Phase 2: Simultaneous enthalpic and entropic gains, improving affinity 25-fold.
  • Phase 3: Trend collapse with functionalities larger than the cavity, causing significant enthalpy and affinity losses.

Conclusions:

  • Van der Waals interactions play a critical role in modulating binding affinity.
  • Distinct thermodynamic phases offer insights into binding mechanisms.
  • The observed thermodynamic signatures provide valuable guidelines for lead optimization in drug discovery.